
News|Articles|March 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 18, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, March 18, 2022, at 4:54 PM, EDT:
44.5% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of today, March 18, 2022, at 4:54 PM, EDT:
• 65.3% of total US population
• 69.5% of US population aged ≥5 years
• 73.8% of US population aged ≥12 years
• 75.3% of US population aged ≥18 years
• 88.9% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 81.9%
2. Rhode Island: 81.3%
3. Vermont: 80.5%
4. Maine: 78.6%
5. Connecticut: 78.2%
2. Rhode Island: 81.3%
3. Vermont: 80.5%
4. Maine: 78.6%
5. Connecticut: 78.2%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, March 18, 2022 at 4:20 PM, EDT, there have been:
• 79 709 069 confirmed cases and
• 970 744 deaths
• 970 744 deaths
The 5 states with the highest total confirmed cases are:
1. California: 9 059 470
2. Texas: 6 687 554
3. Florida: 5 868 263
4. New York: 4 958 932
5. Illinois: 3 053 185
2. Texas: 6 687 554
3. Florida: 5 868 263
4. New York: 4 958 932
5. Illinois: 3 053 185
Deaths: California has the highest number of deaths due to COVID-19 with 87 967 reported fatalities, followed by Texas with 86 824 and Florida with 72 443.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 466 775 855 confirmed cases, 6 069 197 deaths, and 10 761 481 231 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
2
"Shared Decision-Making" for COVID-19 Vaccination Signals "Optional" to Too Many, Says Kelly Moore, MD, MPH
3
Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
4
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials
5